![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_100a6b13486c9975a61ba5f10cb38eb9.svg) | Yohimbine | IC50 | 3.67 [1], 8.4 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_100a6b13486c9975a61ba5f10cb38eb9.svg) | Yohimbine | Ki | 3.1 [1], 7.5 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_1726a98f5c906c983c15d93ec617b7f6.svg) | Terazosin | Ki | 549.54 [1], 550.0 [2], 1500.0 [3], 3702.0 [4], 5187.0 [5] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_8159b09a6bebd9e5751360e57f770ab8.svg) | Clozapine | Ki | 24.0 [1], 34.0 [2], 185.0 [3], 1000.0 [4] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_e684ff905325760b5d18575644f1108f.svg) | Phentolamine | Ki | 1.7 [1], 2.25 [2], 2.6 [3], 55.9 [4] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_7b0a378e6eb6435a9af3ef94b5296f14.svg) | Idazoxan | IC50 | 8.32 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_7b0a378e6eb6435a9af3ef94b5296f14.svg) | Idazoxan | Ki | 7.08 [1], 8.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_2631acefb622fef6f50e00597cf689fd.svg) | 2-[1-(2-Prop-2-enylphenoxy)ethyl]-4,5-dihydro-1H-imidazole | Ki | 57.54 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_628cf5c819819c75fc97c108403b82dd.svg) | Methyl 5-[3-(4,4-diphenylpiperidin-1-yl)propylcarbamoyl]-2,6-dimethyl-4-(4-nitrophenyl)-1,4-dihydropyridine-3-carboxylate | Ki | 1200.0 [1], 1202.26 [2], 2417.0 [3], 3300.0 [4] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_215a9931cb11cf1c644271d4a487d831.svg) | 2-[1-(2-Biphenylyloxy)ethyl]-2-imidazoline | Ki | 47.86 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_8b7abc48edf30a2538d03e3d1bf746fe.svg) | (3R,3As)-7,8-dimethoxy-3-[[4-[(E)-2-methyl-3-phenylprop-2-enyl]piperazin-1-yl]methyl]-3a,4-dihydro-3H-chromeno[4,3-c][1,2]oxazole | Ki | 0.3 [1], 0.8 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_79bd9e6d4ab943f8b2cd1d58bcadd7d7.svg) | (3R,3As)-7,8-dimethoxy-3-[[4-[(E)-3-phenylbut-2-enyl]piperazin-1-yl]methyl]-3a,4-dihydro-3H-chromeno[4,3-c][1,2]oxazole | Ki | 0.3 [1], 1.4 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_be4565ca8c20c1d9804fa640fd1584d5.svg) | Risperidone | Ki | 3.63 [1], 10.0 [2], 1000.0 [3] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_8b78ef0953132cb6729f40caa0d6bbea.svg) | Olanzapine | Ki | 192.0 [1], 203.0 [2], 1000.0 [3] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_ebac36f7213da3162d29205ab4152aca.svg) | Prazosin | Ki | 210.0 [1], 989.0 [2], 2133.0 [3] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_b329cb5fecb003fb4c92d7c3545f5228.svg) | Mianserin | IC50 | 20.89 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_b329cb5fecb003fb4c92d7c3545f5228.svg) | Mianserin | Ki | 4.8 [1], 16.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_6bd8428f24df55bebd5446ef40e0614c.svg) | Brimonidine | Ki | 2.7 [1], 6.76 [2], 112.0 [3] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_ea0f5584ab0c621398ec482f268c656f.svg) | Oxymetazoline | Ki | 0.29 [1], 8.64 [2], 16.22 [3] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_cff59dd686ac48dc984e2eb35145cf4a.svg) | Rilmenidine | Ki | 36.31 [1], 181.97 [2], 300.0 [3] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_f897971ee0e4deb8cc0cacdfe39bc83e.svg) | Atipamezole | Ki | 1.2 [1], 1.86 [2], 3.16 [3] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_d70a81e024e37dc8dc5b94ad4f093ec9.svg) | N,N-Dimethyl-1-(3-oxa-2-azatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),7,9,11,14,16-hexaen-4-yl)methanamine | IC50 | 371.54 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_aa21024c09830ea2a641fb75928c2842.svg) | 3-[2-[1-(4,5-Dihydro-1H-imidazol-2-yl)ethoxy]phenyl]phenol | Ki | 27.54 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_92d0f3c9cc971f2e63f8616b5df30b68.svg) | 2-[1-[2-(3-Nitrophenyl)phenoxy]ethyl]-4,5-dihydro-1H-imidazole | Ki | 60.26 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_19486e79148b6b1ab710f15154d58c1f.svg) | (3R,3As)-7,8-dimethoxy-3-[[4-[(E)-3-phenylprop-2-enyl]piperazin-1-yl]methyl]-3a,4-dihydro-3H-chromeno[4,3-c][1,2]oxazole | Ki | 2.6 [1], 8.8 [2], 25.0 [3] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_ea6cb83269b6a18e3c0ec5ba6f4d99ca.svg) | 2-[(1S)-1-(2-Prop-2-enylphenoxy)ethyl]-4,5-dihydro-1H-imidazole | Ki | 52.48 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_024da52c2da9515a55d1fb877fe1584a.svg) | 2-[(1R)-1-(2-Prop-2-enylphenoxy)ethyl]-4,5-dihydro-1H-imidazole | Ki | 100.0 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_3573f5c91adad946c6bf8cec81498164.svg) | 2-[1-[2-(Cyclopropylmethyl)phenoxy]ethyl]-4,5-dihydro-1H-imidazole | Ki | 36.31 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_ff07b3638c134a3eacd7851325d66c98.svg) | Unii-G7fms28pyd | IC50 | 1100.0 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_ff07b3638c134a3eacd7851325d66c98.svg) | Unii-G7fms28pyd | Ki | 411.0 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_712d7bf3cb291229e4b03575585bc48f.svg) | N-(4,5-Dihydro-1H-imidazol-2-yl)-5-methylquinoxalin-6-amine | Ki | 2.0 [1], 7.24 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_9f23f1177b91903791ed61e0631346ce.svg) | (3R,3As)-7,8-dimethoxy-3-[[4-(naphthalen-2-ylmethyl)piperazin-1-yl]methyl]-3a,4-dihydro-3H-chromeno[4,3-c][1,2]oxazole | Ki | 1.3 [1], 5.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_028b726b0bd4cfab1950425844ad1058.svg) | Epinephrine | Ki | 160.0 [1], 276.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_c871e436119b1d6f92ea7571ed4647e5.svg) | Quetiapine | Ki | 934.3 [1], 1000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_841aee148f923620dd466429acf932bb.svg) | Mirtazapine | IC50 | 85.11 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_841aee148f923620dd466429acf932bb.svg) | Mirtazapine | Ki | 20.0 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_fe0752a8b8d7dcc41cb04f6c3cbe759b.svg) | Tamsulosin | Ki | 13.4 [1], 63.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_99243ad70f3782906d99e25d725ca7ff.svg) | Clemastine | Ki | 69.0 [1], 169.82 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_5216a3e2c19e603317cf33ffb19df9ac.svg) | Cirazoline | Ki | 58.88 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_45dcbd1bf64013c2b1cc683f9b147e16.svg) | Niguldipine | Ki | 530.0 [1], 645.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_35189598ddecb63ddaf2b7cf9d358a69.svg) | Unii-22xbk6DY1E | Ki | 114.0 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_7e67dc53b9dda9b460fb3afbfa5076d7.svg) | N,N-Diallyl-5-methoxytryptamine | Ki | 213.8 [1], 10000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_a4d5d0e2fba3e84871d4fe0ec62b9e35.svg) | ATC-0175 free base | IC50 | 104.0 [1], 260.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_64ef923c303f14c5288691bd20a22703.svg) | 1H-Imidazole, 4,5-dihydro-2-(1-phenoxyethyl)- | Ki | 26.92 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_4a0786f70766598abe923b7c90d75e71.svg) | Ethanesulfonamide, N-(3-(1H-imidazol-4-ylmethyl)phenyl)- | Ki | 169.82 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_ed0696f4063527c90599e250ac09b094.svg) | 2-(1-Benzofuran-6-yl)-N-[[(1R)-5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl]methyl]-N-methylethanamine | Ki | 2.4 [1], 2.5 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_4a13570c4106131c22ba887ec7fdec50.svg) | 2-[(1S)-1-(2-Phenylphenoxy)ethyl]-4,5-dihydro-1H-imidazole | Ki | 91.2 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_9bc49b50df2b2aec932f139a88a8441a.svg) | 4-(5-Fluoro-2-indanylmethyl)-2-imidazoline | Ki | 5.9 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_f55cc3c3d081e9b01c9a5590a44a3b44.svg) | 5-N-[3-(4,4-Diphenylpiperidin-1-yl)propyl]-3-N,2,6-trimethyl-4-(4-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxamide | Ki | 398.0 [1], 398.11 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_8f7bb7171dc7072740515ad7d2657803.svg) | 2-[(1R)-1-(2-Phenylphenoxy)ethyl]-4,5-dihydro-1H-imidazole | Ki | 186.21 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_353de4856aad482e432e828dd0efa8b5.svg) | 5-N-[3-(4,4-Diphenylpiperidin-1-yl)propyl]-2,6-dimethyl-4-(4-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxamide | Ki | 148.0 [1], 371.54 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_074cdccd9b9a3042d2200e59f90272ac.svg) | 1-(17-Chloro-3-oxa-2-azatetracyclo[12.4.0.02,6.07,12]octadeca-1(14),7,9,11,15,17-hexaen-4-yl)-N,N-dimethylmethanamine | IC50 | 478.63 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_c6e8b27d5f47c9da347139aa6c863a6c.svg) | 1-Benzyl-4-chroman-2-ylmethyl-piperazine | Ki | 146.1 [1], 167.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_8514bebba5223babb6c05290cd6ef8c8.svg) | 4-Bromo-N-[4-[[4-(dimethylamino)quinazolin-2-yl]amino]cyclohexyl]-2-(trifluoromethoxy)benzenesulfonamide | IC50 | 47.0 [1], 57.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_0782d21c3b55c3b9637817bff3561d2a.svg) | 2-[1-[2-(3-Fluorophenyl)phenoxy]ethyl]-4,5-dihydro-1H-imidazole | Ki | 14.79 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_4c9db4c3c8c989bcac7236e470fb26f8.svg) | 3-[2-[1-(4,5-Dihydro-1H-imidazol-2-yl)ethoxy]phenyl]pyridine | Ki | 138.04 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_f0c6efd38010786038edbb3ed98d2d04.svg) | 4-Bromo-N-[[4-[[4-(dimethylamino)quinazolin-2-yl]amino]cyclohexyl]methyl]-2-(trifluoromethoxy)benzenesulfonamide | IC50 | 110.0 [1], 130.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_a4fdc2d9a60da7ea30540d4a17e53c98.svg) | 2-N-[1-[4-Bromo-2-(trifluoromethoxy)phenyl]sulfonylpiperidin-4-yl]-4-N,4-N-dimethylquinazoline-2,4-diamine | IC50 | 170.0 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_660508df601529abf07204cf1202157f.svg) | 2-[1-(2-Thiophen-3-ylphenoxy)ethyl]-4,5-dihydro-1H-imidazole | Ki | 45.71 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_634f3e7a047442c41883058dc544b2e4.svg) | (3R,3As)-3-[[4-[(E)-3-(4-fluorophenyl)-2-methylprop-2-enyl]piperazin-1-yl]methyl]-7,8-dimethoxy-3a,4-dihydro-3H-chromeno[4,3-c][1,2]oxazole | Ki | 3.4 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_b3c827abeea9e12efe9571a0e1d4378b.svg) | (R)-3-Nitrobiphenyline | Ki | 81.28 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_774443f432049c7821df7e83f28ea2ae.svg) | 2-[(1S)-1-[2-(3-Nitrophenyl)phenoxy]ethyl]-4,5-dihydro-1H-imidazole | Ki | 72.44 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_00d377c7f38eeb0707ff1fb3aea8b3fc.svg) | (3R,3As)-7,8-dimethoxy-3-[[4-[(Z)-3-phenylprop-2-enyl]piperazin-1-yl]methyl]-3a,4-dihydro-3H-chromeno[4,3-c][1,2]oxazole | Ki | 23.0 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_0a6f09d9399e627cb4c92b9f053304d0.svg) | 2-[1-(2-Cyclopropylphenoxy)ethyl]-4,5-dihydro-1H-imidazole | Ki | 22.91 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_ee26655c5cb74fd95008137822479c1c.svg) | 2-[(1S)-1-(2-Cyclopropylphenoxy)ethyl]-4,5-dihydro-1H-imidazole | Ki | 20.89 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_73f35657f82d2f052f7b5e42cf39f1c6.svg) | 2-[(1R)-1-(2-Cyclopropylphenoxy)ethyl]-4,5-dihydro-1H-imidazole | Ki | 44.67 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_64b71e1d55efb4c6d312dfa5d78a9780.svg) | (8S)-N-[2-(3-Fluorophenyl)ethyl]pentacyclo[5.4.0.02,6.03,10.05,9]undecan-8-amine | Ki | 7609.0 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_40e0bef9ea934cba3679c1f515ac109d.svg) | 2-(1-(2-Bromophenoxy)ethyl)-4,5-dihydro-1H-imidazole | Ki | 22.91 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_105da008d9e9b9b6d5355bd717d3417c.svg) | 2-[1-(2-Cyclopropyloxyphenoxy)ethyl]-4,5-dihydro-1H-imidazole | Ki | 83.18 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_1605af5397272b6a0e6da41fcdc86be4.svg) | 2-[(1R)-1-[2-(Cyclopropylmethyl)phenoxy]ethyl]-4,5-dihydro-1H-imidazole | Ki | 44.67 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_6dd552bbcd9974f243b9111cdb8effe6.svg) | 2-[(1S)-1-[2-(Cyclopropylmethyl)phenoxy]ethyl]-4,5-dihydro-1H-imidazole | Ki | 41.69 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_7b6e651dd1176da56cf46d87f01bfbda.svg) | 5-Methyl-1,5-diazapentacyclo[10.8.1.02,7.08,21.013,18]henicosa-2(7),8(21),9,11,13,15,17-heptaene | Ki | 407.0 [1], 407.38 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_6c7c1bedd3a0bcaf7b8527fe16c330ea.svg) | 5-O-[3-(4,4-Diphenylpiperidin-1-yl)propyl] 3-O-methyl 2,6-dimethyl-4-(4-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate | Ki | 800.0 [1], 1023.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_c19f64edaa1404316267acad60bf9d23.svg) | N-[2-[4-[[(3S)-2,3-Dihydro-1,4-benzodioxin-3-yl]methyl]-1,4-diazepan-1-yl]ethyl]-2-phenoxypyridine-3-carboxamide | Ki | 94.4 [1], 442.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_9a8a608424ff76d3b8775cde8a2ae9ec.svg) | 1-((2,3-Dihydrobenzo[b][1,4]dioxin-2-yl)methyl)-4-(2-methoxyphenyl)piperazine | Ki | 167.0 [1], 506.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_4dcff5dfc3294ed999f5ea0061f3dc38.svg) | N-[2-[4-(2,3-Dihydro-1,4-benzodioxin-3-ylmethyl)-1,4-diazepan-1-yl]ethyl]-2-phenoxypyridine-3-carboxamide | Ki | 220.0 [1], 474.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_cf862154afdf503c44660aebef9a0de1.svg) | 2-(3-Cyanophenoxy)-N-[2-[4-(2,3-dihydro-1,4-benzodioxin-3-ylmethyl)-1,4-diazepan-1-yl]ethyl]pyridine-3-carboxamide | Ki | 208.0 [1], 501.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_1925835f77735b51ed20c3b865448845.svg) | 2-(Tert-butylamino)-N-[2-[4-(2,3-dihydro-1,4-benzodioxin-3-ylmethyl)-1,4-diazepan-1-yl]ethyl]pyridine-3-carboxamide | Ki | 138.0 [1], 366.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_b325533f530374041fd5b4ac0a8a8f96.svg) | 2-Butoxy-N-[2-[4-(2,3-dihydro-1,4-benzodioxin-3-ylmethyl)-1,4-diazepan-1-yl]ethyl]pyridine-3-carboxamide | Ki | 73.6 [1], 81.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_a827286c93788c5784f718f830d1b912.svg) | 6-Butoxy-N-[2-[4-(2,3-dihydro-1,4-benzodioxin-3-ylmethyl)-1,4-diazepan-1-yl]ethyl]pyridine-2-carboxamide | Ki | 48.4 [1], 118.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_f9771e9ad9575a2fb7eae5e4429783a1.svg) | 1-(2,3-Dihydro-1,4-benzodioxin-3-ylmethyl)-4-[2-[(2-phenoxypyridin-3-yl)methoxy]ethyl]-1,4-diazepane | Ki | 66.1 [1], 275.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_ab7e97569dd0e8b8d9ae86a071b58134.svg) | 5-[[4-(2,3-Dihydro-1,4-benzodioxin-3-ylmethyl)-1,4-diazepan-1-yl]methyl]-3-(2-phenoxypyridin-3-yl)-1,2,4-oxadiazole | Ki | 15.4 [1], 44.8 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_d6baf9cef7bd06b4eeb691b6bce54993.svg) | 4-Bromo-N-[[4-[[[4-(dimethylamino)quinazolin-2-yl]amino]methyl]cyclohexyl]methyl]-2-(trifluoromethoxy)benzenesulfonamide | IC50 | 7.7 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_13ca8a7707d990fde72fc2db625d91c5.svg) | Norepinephrine | Ki | 66.0 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_c70f5b79af37726016ec15cea0b55e94.svg) | Propranolol | IC50 | 5011.87 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_b2d55887aa13c1a8af23a97683daa661.svg) | Vancomycin | Ki | 50.12 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_01814a6086009d7440d5f435a324c600.svg) | Verapamil | Ki | 217.0 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_f28ce47318433f5c984060ce11c4a797.svg) | Tamoxifen | Ki | 726.0 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_a7e11d7bcee94c9af8c42c557a082c25.svg) | Chlorpromazine | Ki | 132.0 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_7ce5c90b273b41810bee3170ac9401d3.svg) | Haloperidol | Ki | 1865.0 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_693b10fcf0f1bf3ce26f73cb27aee812.svg) | Fluoxetine | Ki | 6.31 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_923918ca2b63f82fdc23b9aff249ab4c.svg) | Chloroquine | Ki | 4365.16 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_c3fc0e31bc6ec8063f62dfd5e15cabe9.svg) | Ticlopidine | Ki | 143.0 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_aa9d9a16ebe5f6dc4edbdd7657f94691.svg) | Clonidine hydrochloride | Ki | 20.89 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_81af8877c0a8c32165f86d729092ee41.svg) | Amiodarone | Ki | 117.0 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_946b0b501eb57b26c13e79111c2b1587.svg) | Amitriptyline | Ki | 132.0 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_a69f1db31ed30d6a63db389cb16202f2.svg) | Ketoconazole | Ki | 7419.0 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_adf25e33d7987b11abe6dedf76999efd.svg) | Diethylstilbestrol | Ki | 5297.0 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2a-adrenergic-receptor_b245c9e25780678ea441c35a3d085042.svg) | Bromocriptine | Ki | 5.53 [1] |